Epstein-Barr virus in breast cancer: Artefact or aetiological agent?

Journal of Pathology

Volumn 209, Issue 4, 2006, Pages 427-429

  Murray, P G ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Antibody; Antigen; Cancer testis; EBNA1; Epstein Barr virus; Immunohistochemistry; MAGE4

Indexed keywords

BIOLOGICAL MARKER; CANCER TESTIS ANTIGEN; PROTEIN ANTIBODY; VIRUS PROTEIN;

ANTIGEN EXPRESSION; ARTIFACT; BREAST CANCER; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; METHODOLOGY; NOTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; VIRUS DETECTION; VIRUS LATENCY;

ANTIBODIES, VIRAL; ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CROSS REACTIONS; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; VIRUS LATENCY;

EID: 33746862217     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2032     Document Type: Note

References (22)

1. Young LS, Murray PG. Epstein-Baff virus and oncogenesis: from latent genes to tumours. Oncogene 2003;22:5108-5121.
2. Labrecque LG, Barnes DM, Fentiman IS, Griffin BE. Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res 1995;55:39-45.
3. Luqmani YA, Shousha S. Presence of Epstein-Barr virus in breast carcinoma. Int J Oncol 1995;6:899-903.
4. Bonnet M, Guinebretiere JM, Kremmer E, Grunewald V, Benhamou E, Contesso G, et al. Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 1999;91:1376-1381.
5. McCall SA, Lichy JH, Bijwaard KE, Aguilera NS, Chu WS, Taubenberger JK. Epstein-Barr virus detection in ductal carcinoma of the breast. J Natl Cancer Inst 2001;93:148-150.
6. Fina F, Romain S, Ouafik L, Palmari J, Ben Ayed F, Benharkat S, et al. Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas. Br J Cancer 2001;84:783-790.
7. Chu PG, Chang KL, Chen YY, Chen WG, Weiss LM. No significant association of Epstein-Barr virus infection with invasive breast carcinoma. Am J Pathol 2001;159:571-578.
8. Chu JS, Chen CC, Chang KJ. In situ detection of Epstein-Barr virus in breast cancer. Cancer Lett 1998;124:53-57.
9. Brink AATP, van den Brule AJC, van Diest P, Meijer CJLM. Re: Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 2000;92:655-656.
10. Kijima Y, Hokita S, Takao S, Baba M, Natsugoe S, Yoshinaka H, et al. Epstein-Barr virus involvement is mainly restricted to lymphoepithelial type of gastric carcinoma among various epithelial neoplasms. J Med Virol 2001;64:513-518.
11. Deshpande CG, Badve S, Kidwai N, Longnecker R. Lack of expression of the Epstein-Barr Virus (EBV) gene products, EBERs, EBNA1, LMP1, and LMP2A, in breast cancer cells. Lab Invest 2002;82:1193-1199.
12. Herrmann K, Niedobitek G. Lack of evidence for an association of Epstein-Barr virus infection with breast carcinoma. Breast Cancer Res 2003;5:R13-R17.
13. Sugawara Y, Mizugaki Y, Uchida T, Torii T, Imai S, Makuuchi M, et al. Detection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression. Virology 1999;256:196-202.
14. Junying J, Herrmann K, Davies G, Lissauer D, Bell A, Timms J, et al. Absence of Epstein-Barr virus DNA in the tumor cells of European hepatocellular carcinoma. Virology 2003;306:236-243.
15. Murray PG, Lissauer D, Junying J, Davies G, Moore S, Bell A, et al. Reactivity with a monoclonal antibody to Epstein-Barr virus (EBV) nuclear antigen 1 defines a subset of aggressive breast cancers in the absence of the EBV genome. Cancer Res 2003;63:2338-2343.
16. Huang J, Chen H, Hutt-Fletcher L, Ambinder RF, Hayward SD. Lytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancer. J Virol 2003;77:13267-13274.
17. Arbach H, Viglasky V, Lefeu F, Guinebretiere JM, Ramirez V, Bride N, et al. Epstein-Barr virus (EBV) genome and expression in breast cancer tissue: effect of EBV infection of breast cancer cells on resistance to paclitaxel (Taxol). J Virol 2006;80:845-853.
18. Grasser FA, Murray PG, Kremmer E, Klein K, Remberger K, Feiden W, et al. Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1). Inummohistologic detection of EBNA1 in the malignant cells of Hodgkin's disease. Blood 1994;84:3792-3798.
19. Preciado MV, Chabay PA, De Matteo EN, Gonzalez P, Grinstein S, Actis A, et al. Epstein-Barr virus in breast carcinoma in Argentina. Arch Pathol Lab Med 2005;129:377-381.
20. Grinstein S, Preciado MV, Gattuso P, Chabay PA, Warren WH, De Matteo E, et al. Demonstration of Epstein-Barr virus in carcinomas of various sites. Cancer Res 2002;62:4876-4878.
21. Restelli M, Grinstein S, Gattuso P, Preciado MV, Brunzini MA, Zarate J, et al. Immunolocalization of the Epstein-Barr nuclear antigen-1 in conjunctival squamous carcinomas and dysplasias. Hum Pathol 2005;36:325-329.
22. Hermard C, Pfuhl T, Buettner M, Becker K-F, Knöfel T, Middeldorp J, et al. The antibody 2134 directed against the Epstein-Barr virus (EBV)-encoded nuclear antigen 1 (EBNA1) detects MAGE-4: implications for studies on the EBV-association of human cancers. J Pathol 2006;209:430-435.